{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:15:27Z","timestamp":1794273327934,"version":"4.9.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1038\/s41433-020-1013-y","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T14:02:44Z","timestamp":1591711364000},"page":"979-987","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Role of combined immunomodulator therapy in severe steroid intolerant vernal keratoconjunctivitis"],"prefix":"10.1038","volume":"35","author":[{"given":"Prafulla Kumar","family":"Maharana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimmy","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6631-2099","authenticated-orcid":false,"given":"Jeewan S.","family":"Titiyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"key":"1013_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1755-3768.2008.01347.x","volume":"87","author":"S Kumar","year":"2009","unstructured":"Kumar S. Vernal keratoconjunctivitis: a major review. Acta Ophthalmol. 2009;87:133\u201347.","journal-title":"Acta Ophthalmol"},{"key":"1013_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.survophthal.2018.12.001","volume":"64","author":"D Singhal","year":"2019","unstructured":"Singhal D, Sahay P, Maharana PK, Raj N, Sharma N, Titiyal JS. Vernal keratoconjunctivitis. Surv Ophthalmol. 2019;64:289\u2013311.","journal-title":"Surv Ophthalmol"},{"key":"1013_CR3","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2147\/OPTH.S32936","volume":"6","author":"M Ang","year":"2012","unstructured":"Ang M, Ti S-E, Loh R, Farzavandi S, Zhang R, Tan D, et al. Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis. Clin Opthalmol. 2012;6:1253\u20138.","journal-title":"Clin Opthalmol"},{"key":"1013_CR4","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1111\/j.1442-9071.2011.02591.x","volume":"40","author":"M Ang","year":"2012","unstructured":"Ang M, Ho C-L, Tan D, Chan C. Severe vernal keratoconjunctivitis requiring trabeculectomy with mitomycin C for corticosteroid-induced glaucoma. Clin Exp Ophthalmol. 2012;40:e149\u2013155.","journal-title":"Clin Exp Ophthalmol"},{"key":"1013_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4103\/ojo.OJO_232_2014","volume":"10","author":"AM Al-Amri","year":"2017","unstructured":"Al-Amri AM, Fiorentini SF, Albarry MA, Bamahfouz AY. Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis. Oman J Ophthalmol. 2017;10:145\u20139.","journal-title":"Oman J Ophthalmol"},{"key":"1013_CR6","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1097\/ICO.0000000000000918","volume":"35","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee S, Agrawal D. Tacrolimus in corticosteroid-refractory vernal keratoconjunctivitis. Cornea. 2016;35:1444\u20138.","journal-title":"Cornea"},{"key":"1013_CR7","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1177\/039463201002300322","volume":"23","author":"N Pucci","year":"2010","unstructured":"Pucci N, Caputo R, Mori F, De Libero C, Di Grande L, Massai C, et al. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis. Int J Immunopathol Pharmacol. 2010;23:865\u201371.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1013_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/pai.12360","volume":"26","author":"N Pucci","year":"2015","unstructured":"Pucci N, Caputo R, di Grande L, de Libero C, Mori F, Barni S, et al. Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: a randomized, comparative, double-blind, crossover study. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2015;26:256\u201361.","journal-title":"Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol"},{"key":"1013_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/ACI.0000000000000560","volume":"19","author":"N Erdinest","year":"2019","unstructured":"Erdinest N, Ben-Eli H, Solomon A. Topical tacrolimus for allergic eye diseases. Curr Opin Allergy Clin Immunol. 2019;19:535\u201343.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"1013_CR10","first-page":"128","volume":"9","author":"R Kumari","year":"2017","unstructured":"Kumari R, Saha BC, Sinha BP, Mohan N. Tacrolimus versus cyclosporine- comparative evaluation as first line drug in vernal keratoconjuctivitis. Nepal J Ophthalmol Biannu Peer-Rev Acad J Nepal Ophthalmic Soc NEPJOPH. 2017;9:128\u201335.","journal-title":"Nepal J Ophthalmol Biannu Peer-Rev Acad J Nepal Ophthalmic Soc NEPJOPH"},{"key":"1013_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s11882-013-0345-0","volume":"13","author":"P Vichyanond","year":"2013","unstructured":"Vichyanond P, Kosrirukvongs P. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis. Curr Allergy Asthma Rep. 2013;13:308\u201314.","journal-title":"Curr Allergy Asthma Rep"},{"key":"1013_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1350-9462(02)00006-X","volume":"21","author":"A Leonardi","year":"2002","unstructured":"Leonardi A. Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Retin Eye Res. 2002;21:319\u201339.","journal-title":"Prog Retin Eye Res"},{"key":"1013_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jaci.2003.10.065","volume":"113","author":"P Vichyanond","year":"2004","unstructured":"Vichyanond P, Tantimongkolsuk C, Dumrongkigchaiporn P, Jirapongsananuruk O, Visitsunthorn N, Kosrirukvongs P. Vernal keratoconjunctivitis: result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment. J Allergy Clin Immunol. 2004;113:355\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"1013_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2147\/OPTH.S99157","volume":"10","author":"SS Shoughy","year":"2016","unstructured":"Shoughy SS, Jaroudi MO, Tabbara KF. Efficacy and safety of low-dose topical tacrolimus in vernal keratoconjunctivitis. Clin Ophthalmol. 2016;10:643\u20137.","journal-title":"Clin Ophthalmol"},{"key":"1013_CR15","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/eye.2011.75","volume":"25","author":"A Kheirkhah","year":"2011","unstructured":"Kheirkhah A, Zavareh MK, Farzbod F, Mahbod M, Behrouz MJ. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis. Eye. 2011;25:872\u201380.","journal-title":"Eye"},{"key":"1013_CR16","first-page":"410","volume":"56","author":"M \u00c7oban-Karata\u015f","year":"2014","unstructured":"\u00c7oban-Karata\u015f M, \u00d6zkale Y, Altan-Yayc\u0131o\u011flu R, S\u0131zmaz S, Pelit A, Metindo\u011fan S, et al. Efficacy of topical 0.05% cyclosporine treatment in children with severe vernal keratoconjunctivitis. Turk J Pediatr. 2014;56:410\u20137.","journal-title":"Turk J Pediatr"},{"key":"1013_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.17219\/acem\/37145","volume":"23","author":"U Keklikci","year":"2014","unstructured":"Keklikci U, Dursun B, Cingu AK. Topical cyclosporine a 0.05% eyedrops in the treatment of vernal keratoconjunctivitis\u2014randomized placebo-controlled trial. Adv Clin Exp Med Organ Wroclaw Med Univ. 2014;23:455\u201361.","journal-title":"Adv Clin Exp Med Organ Wroclaw Med Univ"},{"key":"1013_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1046\/j.1365-2222.2003.01538.x","volume":"33","author":"N Pucci","year":"2003","unstructured":"Pucci N, Novembre E, Lombardi E, Cianferoni A, Bernardini R, Massai C, et al. Atopy and serum eosinophil cationic protein in 110 white children with vernal keratoconjunctivitis: differences between tarsal and limbal forms. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2003;33:325\u201330.","journal-title":"Clin Exp Allergy J Br Soc Allergy Clin Immunol"},{"key":"1013_CR19","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1080\/02713683.2019.1600197","volume":"44","author":"J Shoji","year":"2019","unstructured":"Shoji J, Ohashi Y, Fukushima A, Miyazaki D, Uchio E, Takamura E, et al. Topical tacrolimus for chronic allergic conjunctival disease with and without atopic dermatitis. Curr Eye Res. 2019;44:796\u2013805.","journal-title":"Curr Eye Res"},{"key":"1013_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5935\/0004-2749.20170038","volume":"80","author":"EG M\u00fcller","year":"2017","unstructured":"M\u00fcller EG, Santos MSD, Freitas D, Gomes J\u00c1P, Belfort R. Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial. Arq Bras Oftalmol. 2017;80:154\u20138.","journal-title":"Arq Bras Oftalmol"},{"key":"1013_CR21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ajo.2013.10.006","volume":"157","author":"AM Al-Amri","year":"2014","unstructured":"Al-Amri AM. Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis. Am J Ophthalmol. 2014;157:280\u20136.","journal-title":"Am J Ophthalmol"},{"key":"1013_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/FPC.0b013e328364db84","volume":"23","author":"JM Barbarino","year":"2013","unstructured":"Barbarino JM, Staatz CE, Venkataramanan R, Klein TE, Altman RB. PharmGKB summary: cyclosporine and tacrolimus pathways. Pharmacogenet Genom. 2013;23:563\u201385.","journal-title":"Pharmacogenet Genom"},{"key":"1013_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/ICO.0b013e31822481c2","volume":"31","author":"JH Tzu","year":"2012","unstructured":"Tzu JH, Utine CA, Stern ME, Akpek EK. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis. Cornea. 2012;31:649\u201354.","journal-title":"Cornea"},{"key":"1013_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/ICL.0000000000000001","volume":"40","author":"GG M\u00fcller","year":"2014","unstructured":"M\u00fcller GG, Jos\u00e9 NK, de Castro RS. Topical tacrolimus 0.03% as sole therapy in vernal keratoconjunctivitis: a randomized double-masked study. Eye Contact Lens. 2014;40:79\u201383.","journal-title":"Eye Contact Lens"},{"key":"1013_CR25","first-page":"177","volume":"30","author":"P Labcharoenwongs","year":"2012","unstructured":"Labcharoenwongs P, Jirapongsananuruk O, Visitsunthorn N, Kosrirukvongs P, Saengin P, Vichyanond P. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children. Asian Pac J Allergy Immunol. 2012;30:177\u201384.","journal-title":"Asian Pac J Allergy Immunol"},{"key":"1013_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.5935\/0004-2749.20170052","volume":"80","author":"VL Liendo","year":"2017","unstructured":"Liendo VL, Vola ME, Barreiro TP, Wakamatsu TH, Gomes J\u00c1P, Santos MSD. Topical tacrolimus for the treatment of severe allergic keratoconjunctivitis in children. Arq Bras Oftalmol. 2017;80:211\u20134.","journal-title":"Arq Bras Oftalmol"},{"key":"1013_CR27","first-page":"508","volume":"115","author":"E Takamura","year":"2011","unstructured":"Takamura E, Uchio E, Ebihara N, Okamoto S, Kumagai N, Shoji J, et al. [A prospective, observational, all-prescribed-patients study of cyclosporine 0.1% ophthalmic solution in the treatment of vernal keratoconjunctivitis]. Nippon Ganka Gakkai Zasshi. 2011;115:508\u201315.","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"1013_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/CLEP.S146442","volume":"10","author":"J Castellsague","year":"2018","unstructured":"Castellsague J, Kuiper JG, Potteg\u00e5rd A, Anveden Berglind I, Dedman D, Gutierrez L, et al. A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation\u2014JOELLE study). Clin Epidemiol. 2018;10:299\u2013310.","journal-title":"Clin Epidemiol"},{"key":"1013_CR29","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jaad.2015.02.1116","volume":"72","author":"L Legendre","year":"2015","unstructured":"Legendre L, Barnetche T, Mazereeuw-Hautier J, Meyer N, Murrell D, Paul C. Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: a systematic review and meta-analysis. J Am Acad Dermatol. 2015;72:992\u20131002.","journal-title":"J Am Acad Dermatol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-1013-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-1013-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-1013-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:12:09Z","timestamp":1684617129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-1013-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1013"],"URL":"https:\/\/doi.org\/10.1038\/s41433-020-1013-y","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]},"assertion":[{"value":"23 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}